You have 9 free searches left this month | for more free features.

Mineralocorticoid Receptor Antagonists

Showing 1 - 25 of 8,345

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Renin Angiotensin Aldosterone System Genetic Polymorphism on

Recruiting
  • Myocardial Infarction
    • Cairo, Egypt
      Ain Shams University
    May 16, 2023

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    s to Learn More About Treatment With Steroidal Mineralocorticoid

    Active, not recruiting
    • Chronic Kidney Disease
    • +2 more
    • sMRA therapies
    • Whippany, New Jersey
      Many Locations
    Jan 30, 2023

    Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical

    Not yet recruiting
    • Primary Hyperaldosteronism Due to Adrenal Adenoma
    • Unilateral adrenalectomy
    • Medical treatment (eplerenone)
    • Gothenburg, Sweden
    • +2 more
    Mar 30, 2023

    Heart Failure With Reduced Ejection Fraction Trial in New Haven (Best Practice Alert)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Best Practice Alert
    • New Haven, Connecticut
      Cardiology/Internal Medicine Outpatient Clinics of Yale New Heal
    Jan 17, 2022

    Heart Failure Trial in Worldwide (Spironolacton)

    Completed
    • Heart Failure
    • Corbeil-Essonnes, France
    • +8 more
    Mar 7, 2022

    Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)

    Recruiting
    • Heart Failure
    • Hyperkalemia
    • Sodium zirconium cyclosilicate
    • Placebo
    • Gothenburg, Sweden
      Sahlgrenska University Hospital-Ostra Hospital
    Sep 20, 2021

    STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)

    Not yet recruiting
    • STEMI - ST Elevation Myocardial Infarction
    • Left Ventricular Systolic Dysfunction
    • Dapagliflozin 10Mg Tab
    • Placebo
    • (no location specified)
    Sep 6, 2021

    Chronic Kidney Disease, Albuminuria Trial in Birmingham (Spironolactone, Amiloride)

    Completed
    • Chronic Kidney Disease
    • Albuminuria
    • Birmingham, Alabama
      Hypertension Research Clinic at UAB
    Nov 21, 2022

    Hypertension, Left Ventricular Hypertrophy Trial (Eplerenone, Chlorthalidone, Potassium)

    Not yet recruiting
    • Hypertension
    • Left Ventricular Hypertrophy
    • (no location specified)
    Oct 26, 2022

    Chronic Kidney Diseases Trial (Mineralocorticoid receptor antagonist, Placebo)

    Not yet recruiting
    • Chronic Kidney Diseases
    • Mineralocorticoid receptor antagonist
    • Placebo
    • (no location specified)
    Sep 21, 2023

    Heart Failure Trial in Worldwide (OPTIMIZER, Optimal medical therapy)

    Terminated
    • Heart Failure
    • OPTIMIZER
    • Optimal medical therapy
    • Graz, Austria
    • +7 more
    Sep 1, 2020

    Metabolic Syndrome, Hypertension, Overweight and Obesity Trial in Boston (Eplerenone, Chlorthalidone with potassium chloride)

    Recruiting
    • Metabolic Syndrome
    • +2 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 28, 2022

    Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

    Not yet recruiting
    • Breast Cancer
    • Chemotherapy-induced Nausea and Vomiting
    • Hanzhou, Zhejiang, China
      the Second Affiliated Hospital of Zhejiang Univercity School of
    Apr 23, 2023

    Atherosclerosis Trial in Cleveland (Spironolactone, Placebo)

    Completed
    • Atherosclerosis
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Sep 16, 2022

    Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

    Not yet recruiting
    • Primary Aldosteronism
    • Hypertension
    • (no location specified)
    Apr 3, 2023

    Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)

    Not yet recruiting
    • Pediatric Cancer
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    May 23, 2023

    Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)

    Recruiting
    • Alcohol Use Disorder
    • Columbus, Ohio
      The Ohio State University
    Dec 11, 2022

    IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

    Withdrawn
    • Critical Illness Sepsis, Severe
      • (no location specified)
      Jun 13, 2022

      IL-1ß and Its Receptor Antagonists in Treatment of Severe

      Withdrawn
      • Critical Illness
      • Sepsis, Severe
        • (no location specified)
        Jun 13, 2022

        Heart Failure Trial in New York (Spironolactone 100mg, Spironolactone 25mg)

        Completed
        • Heart Failure
        • Spironolactone 100mg
        • Spironolactone 25mg
        • New York, New York
          Columbia University Medical Center
        Jul 24, 2019

        Hypertension Trial in Ann Arbor (Placebo, Eplerenone 50mg)

        Not yet recruiting
        • Hypertension
        • Placebo
        • Eplerenone 50mg
        • Ann Arbor, Michigan
          University of Michigan
        Feb 4, 2022

        Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

        Recruiting
        • Corona Virus Infection
        • ELISA
        • Assiut, Egypt
          AssiutU
        Feb 2, 2023

        Kidney Transplantation for More Than One Year, Patients With a Kidney Transplantation on Cyclosporine Trial in

        Recruiting
        • Kidney Transplantation for More Than One Year
        • Patients With a Kidney Transplantation on Cyclosporine
        • Eplerenone 50mg/day (cross over design)
        • Period without eplerenone (cross over design)
        • Vandœuvre-lès-Nancy, France
          CHRU de Nancy
        Aug 17, 2022